Franklyn G Prendergast Immunome Inc. (IMNM) insider trading activity

IMNM Quotes by TradingView

Franklyn G Prendergast is Director of Immunome Inc.. Currently has a direct ownership of 60,840 shares of IMNM, which is worth approximately $554,252. The most recent transaction as insider was on Oct 02, 2023, when has been sold 60,840 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.8K
0% 3M change
0% 12M change
Total Value Held $554,252

FRANKLYN G PRENDERGAST Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2023
BUY
Grant, award, or other acquisition
-
60,840 Added 50.0%
60,840 Common Stock

Also insider at

VYNT
Vyant Bio, Inc. Healthcare
Director
LLY
ELI LILLY & Co Healthcare
Director
NBSE
NeuBase Therapeutics, Inc. Healthcare
Director
LTRN
Lantern Pharma Inc. Healthcare
Director
FGP

Franklyn G Prendergast

Director
Rutherford, NJ

Track Institutional and Insider Activities on IMNM

Follow Immunome Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMNM shares.

Notify only if

Insider Trading

Get notified when an Immunome Inc. insider buys or sells IMNM shares.

Notify only if

News

Receive news related to Immunome Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMNM